Santen Pharmaceutical Co Ltd ADR SNPHY

Morningstar Rating
$13.08 +0.41 (3.24%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SNPHY is trading at a LOCK|>##pFM premium.
Price
$12.67
Fair Value
LOCK|.Smm%@&R
Uncertainty
!#d
1-Star Price
LOCK|.#WK#$#<
5-Star Price
LOCK|.v$W>%$
Economic Moat
LOCK|^&CW
Capital Allocation
—

Trading Information

Previous Close Price
$12.67
Day Range
$13.08–13.08
52-Week Range
$9.60–13.93
Bid/Ask
$12.70 / $13.08
Shares Outstanding
321.78M
Market Cap
$4.08B
Volume/Avg
100 / 1,788

Key Statistics

Price/Earnings (Normalized)
16.61
Price/Sales
2.16
Dividend Yield (Trailing)
1.88%
Dividend Yield (Forward)
1.88%
Dividend Payment Schedule
Jul, Dec
Total Yield
7.20%

Company Profile

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Core
Total Number of Employees
3,968

Valuation

Metric
SNPHY
Price/Earnings (Normalized)
16.61
Price/Book Value
2.11
Price/Sales
2.16
Price/Cash Flow
10.68
Price/Earnings
SNPHY

Financial Strength

Metric
SNPHY
Quick Ratio
1.94
Current Ratio
2.96
Interest Coverage
25.79
Quick Ratio
SNPHY

Profitability

Metric
SNPHY
Return on Assets (Normalized)
9.57%
Return on Equity (Normalized)
13.42%
Return on Invested Capital (Normalized)
11.10%
Return on Assets
SNPHY

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
LOCK|Wkyr#wBLOCK|Xp<$1T
Johnson & Johnson
JNJ
LOCK|@$R%$GLOCK|&L$688B
AbbVie Inc
ABBV
LOCK|$^ccHnLOCK|PB$521B
Roche Holding AG ADR
RHHBY
LOCK|n?q#TjdLOCK|RC$387B
Merck & Co Inc
MRK
LOCK|n?@VgGhLOCK|q$$364B
Novartis AG ADR
NVS
LOCK|@<@t?Ls<LOCK|qw$303B
AstraZeneca PLC
AZN
LOCK|N>d&jK##LOCK|Q&$287B
Amgen Inc
AMGN
LOCK|$TgqK?FkLOCK|>w$252B
Gilead Sciences Inc
GILD
LOCK|N$&%j!LOCK|G&$208B
Novo Nordisk AS ADR
NVO
LOCK|nZW?JGLOCK|&?&$181B

Sponsor Center